Tue, Dec 31, 5:09 PM, Zacks
RedHill Biopharma Sells ADS - Analyst Blog
RedHill Biopharma recently announced that it entered into a definitive agreement with OrbiMed Israel Partners Limited Partnership the sale of American Depository Shares and warrants in a private placement transaction for $6.0 million.
Tue, Dec 31, 3:45 PM, Zacks
Threshold Pharma Completes Enrolment - Analyst Blog
Threshold Pharma completed enrolling patients in its phase III study, which is being conducted to evaluate TH-302 for the treatment of advanced soft tissue sarcoma.